Clinical Trial Update: Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing carboplatin and etoposide with or without thalidomide in small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Thalidomide (thalidomide)

Snippet

Sponsor: University College, London | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED